Age and outcomes of primary prevention implantable cardioverter-defibrillators in patients with nonischemic systolic heart failure

Circulation

Volumn 136, Issue 19, 2017, Pages 1772-1780

  Elming, Marie Bayer ^a   Nielsen, Jens C ^b   Haarbo, Jens ^a   Videbæk, Lars ^c   Korup, Eva ^d   Signorovitch, James ^f   Olesen, Line Lisbeth ^g   Hildebrandt, Per ^h   Steffensen, Flemming H ⁱ   Bruun, Niels E ^a,d   Eiskjær, Hans ^b   Brandes, Axel ^c   Thøgersen, Anna M ^d,e   Gustafsson, Finn ^a   Egstrup, Kenneth ^c   Videbæk, Regitze ^a   Hassager, Christian ^a   Svendsen, Jesper Hastrup ^a   Høfsten, Dan E ^a   Torp Pedersen, Christian ^d,e   Pehrson, Steen ^a   Køber, Lars ^a   Thune, Jens Jakob ^a,j   more..

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d AALBORG UNIVERSITY   (Denmark)

^e AALBORG UNIVERSITY HOSPITAL   (Denmark)

^f ANALYSIS GROUP   (United States)

^g ZEALAND UNIVERSITY HOSPITAL   (Denmark)

^h Frederiksberg Heart Clinic   (Denmark)

ⁱ LILLEBAELT HOSPITAL   (Denmark)

^j BISPEBJERG HOSPITAL   (Denmark)

more..

Author keywords

Aging; Death; Defibrillators; Heart failure; Implantable; Systolic

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ALL CAUSE MORTALITY; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COMORBIDITY; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HEART VALVE REPLACEMENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; PREVALENCE; PRIORITY JOURNAL; SUDDEN CARDIAC DEATH; SURVIVAL RATE; SYSTOLIC HEART FAILURE; TREATMENT OUTCOME; AGE; CARDIOVERSION; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DEATH, SUDDEN, CARDIAC; DENMARK; DEVICES; HEART FAILURE, SYSTOLIC; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PRIMARY PREVENTION; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; VERY ELDERLY; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DENMARK; ELECTRIC COUNTERSHOCK; FEMALE; HEART FAILURE, SYSTOLIC; HUMANS; KAPLAN-MEIER ESTIMATE; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRIMARY PREVENTION; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85033604152     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.117.028829     Document Type: Article

References (22)

1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després J-P, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jiménez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB, American Heart Association Statistics Committee, Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2016 update: a report from the American Heart Association. Circulation. 2016;133:e38-e360.
2. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert J P, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883. doi: 10.1056/NEJMoa013474.
3. Køber L, Thune JJ, Nielsen JC, Haarbo J, Videbæk L, Korup E, Jensen G, Hildebrandt P, Steffensen FH, Bruun NE, Eiskjær H, Brandes A, Thøgersen AM, Gustafsson F, Egstrup K, Videbæk R, Hassager C, Svendsen JH, Høfsten DE, Torp-Pedersen C, Pehrson S; DANISH Investigators. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375:1221-1230. doi: 10.1056/NEJMoa1608029.
4. Rickenbacher P, Pfsterer M, Burkard T, Kiowski W, Follath F, Burckhardt D, Schindler R, Brunner-La Rocca HP; TIME-CHF Investigators. Why and how do elderly patients with heart failure die? Insights from the TIME-CHF study. Eur J Heart Fail. 2012;14:1218-1229. doi: 10.1093/eurjhf/hfs113.
5. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes D P, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials: AVID, CASH and CIDS studies: Antiarrhythmics vs Implantable Defibrillator Study, Cardiac Arrest Study Hamburg, Canadian Implantable Defibrillator Study. Eur Heart J. 2000;21:2071-2078. doi: 10.1053/euhj.2000.2476.
6. Krahn AD, Connolly SJ, Roberts RS, Gent M; ATMA Investigators. Diminishing proportional risk of sudden death with advancing age: implications for prevention of sudden death. Am Heart J. 2004;147:837-840. doi: 10.1016/j.ahj.2003.12.017.
7. Thune JJ, Pehrson S, Nielsen JC, Haarbo J, Videbæk L, Korup E, Jensen G, Hildebrandt P, Steffensen FH, Bruun NE, Eiskjær H, Brandes A, Thøgersen AM, Egstrup K, Hastrup-Svendsen J, Høfsten DE, Torp-Pedersen C, Køber L. Rationale, design, and baseline characteristics of the DANish randomized, controlled, multicenter study to assess the efficacy of Implantable cardioverter defibrillators in patients with non-ischemic Systolic Heart failure on mortality (DANISH). Am Heart J. 2016;179:136-141. doi: 10.1016/j.ahj.2016.06.016.
8. Sakamoto Y. Akaike Information Criterion Statistics. D Reidel Publishing Company: James T. Austin 903; 1988.
9. Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control. 1974;19:716-723.
10. Song X, Pepe MS. Evaluating markers for selecting a patient's treatment. Biometrics. 2004;60:874-883. doi: 10.1111/j.0006-341X.2004.00242.x.
11. Song X, Zhou XH. Evaluating markers for treatment selection based on survival time. Stat Med. 2011;30:2251-2264. doi: 10.1002/sim.4258.
12. Hess PL, Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, Buxton A, Cappato R, Dorian P, Hallstrom A, Kadish AH, Kudenchuk PJ, Lee KL, Mark DB, Moss AJ, Steinman R, Inoue LY, Sanders G. Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials. Circ Cardiovasc Qual Outcomes. 2015;8:179-186. doi: 10.1161/CIR-COUTCOMES.114.001306.
13. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola V P, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley J P, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC): developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18:891-975. doi: 10.1002/ejhf.592.
14. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:1810-1852. doi: 10.1161/CIR.0b013e31829e8807.
15. Golwala H, Bajaj NS, Arora G, Arora P. Implantable cardioverter-defibrillator for nonischemic cardiomyopathy: an updated meta-analysis. Circulation. 2017;135:201-203. doi: 10.1161./CIRCULATIONAHA.116.026056.
16. Al-Khatib SM, Fonarow GC, Joglar JA, Inoue LYT, Mark DB, Lee KL, Kadish A, Bardy G, Sanders GD. Primary prevention implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy: a meta-analysis. JAMA Cardiol. 2017;2:685-688. doi: 10.1001/jamacardio.2017.0630.
17. Santangeli P, Di Biase L, Dello Russo A, Casella M, Bartoletti S, Santarelli P, Pelargonio G, Natale A. Meta-analysis: age and effectiveness of prophylactic implantable cardioverter-defibrillators. Ann Intern Med. 2010;153:592-599. doi: 10.7326/0003-4819-153-9-201011020-00009.
18. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein D P, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237. doi: 10.1056/NEJMoa043399.
19. Kadish A, Dyer A, Daubert J P, Quigg R, Estes NA, Anderson K P, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151-2158. doi: 10.1056/NEJMoa033088.
20. Lewis EF, Johnson PA, Johnson W, Collins C, Griffin L, Stevenson LW. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant. 2001;20:1016-1024.
21. Ezzat VA, Lee V, Ahsan S, Chow AW, Segal O, Rowland E, Lowe MD, Lambiase PD. A systematic review of ICD complications in randomised controlled trials versus registries: is our 'real-world' data an underestimation? Open Heart. 2015;2:e000198. doi: 10.1136/openhrt-2014-000198.
22. Barra S, Providência R, Paiva L, Heck P, Agarwal S. Implantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerations. Europace. 2015;17:174-186. doi: 10.1093/europace/euu296.